We are live on
!
Find out more
SCPH
scPharmaceuticals
SCPH
SCPH
Delisted
SCPH was delisted on the 6th of October, 2025.
77 hedge funds and large institutions have $121M invested in scPharmaceuticals in 2024 Q2 according to their latest regulatory filings, with 12 funds opening new positions, 30 increasing their positions, 23 reducing their positions, and 11 closing their positions.
New
Increased
Maintained
Reduced
Closed
1,392% more call options, than puts
Call options by funds: $388K | Put options by funds: $26K
30% more repeat investments, than reductions
Existing positions increased: 30 | Existing positions reduced: 23
2.99% more ownership
Funds ownership: 74.17% → 77.16% (+3%)
1% more funds holding
Funds holding: 76 → 77 (+1)
9% more first-time investments, than exits
New positions opened: 12 | Existing positions closed: 11
10% less capital invested
Capital invested by funds: $134M → $121M (-$13.2M)
50% less funds holding in top 10
Funds holding in top 10: 2 → 1 (-1)
Holders
77
Holders Change
+1
Holders Change %
+1.32%
% of All Funds
1.11%
Holding in Top 10
1
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-50%
% of All Funds
0.01%
New
12
Increased
30
Reduced
23
Closed
11
Calls
$388K
Puts
$26K
Net Calls
+$362K
Net Calls Change
-$234K
Top Buyers
Top Sellers
| 1 |
JGC
J. Goldman & Co
New York
|
-$1.09M |
| 2 |
Walleye Capital
New York
|
-$799K |
| 3 |
Ameriprise
Minneapolis,
Minnesota
|
-$431K |
| 4 |
Millennium Management
New York
|
-$259K |
| 5 |
Squarepoint
New York
|
-$188K |
